Conference: Comparative Effectiveness And Personalized Medicine
August 19th, 2010
by
Chris Fleming
|
Susan Dentzer, Health Affairs editor-in-chief, will lead a discussion with speakers and audience in the opening session of ECRI Institute’s 17th annual conference, entitled “Comparative Effectiveness and Personalized Medicine: An Essential Interface.” The conference will be held on the campus of the National Institutes of Health, in Bethesda, MD, October 19 and 20, 2010.
Health Affairs helped to design the program with senior leadership from ECRI Institute, the National Institutes of Health, the Agency for Healthcare Research and Quality, the Kaiser Permanente Institute for Health Policy, the Milbank Memorial Fund, and the Leonard Davis Institute of Health Economics at the University of Pennsylvania. Health Affairs is publishing a themed issue on comparative effectiveness research in October that will address and expand upon many of the themes in this conference.
Drs. Francis Collins, Director of NIH, and Carolyn Clancy, Director of AHRQ, are among our many distinguished presenters. The conference sessions, over a day and a half, are designed to be understandable and useful to a range of healthcare constituencies. The agenda will have significant time devoted to dialog with the audience and for you to meet the speakers.
We look forward to your participation throughout the conference. The program is being Webcast for those who are unable to travel. There is no charge to attend live or participate via Webcast, but registration is required. Space is filling quickly, so early registration is encouraged.
Background
With the advent of healthcare reform, our nation will be embarking on an unprecedented effort to determine which health care intervention works best for the treatment of a given condition or disorder.
The Patient Protection and Affordable Care Act emphasizes the importance of comparative effectiveness research in order to evaluate clinical outcomes across study populations. It also acknowledges the key role of personalized medicine in ensuring the capacity to identify both individual and subgroup differences within populations. The addition of personalized medicine will help clinicians and patients better predict which intervention will deliver the optimal treatment to the appropriate patient at the right time.
This meeting explores two critical streams of scientific inquiry in order to better align evidentiary, infrastructure, and database needs, to highlight research challenges, and to brainstorm about regulatory, ethical, and societal factors affecting both fields. Our aim is to forge new synergies capable of generating innovation in the course of healthcare reform which will result in enhanced health outcomes for the American people.
Email This Post
Print This Post
